bradykinin, des-arg(9)- has been researched along with Arteriosclerosis, Coronary in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Danser, AH; de Maat, MP; Garrelds, IM; Leijten, FP; Musterd-Bhaggoe, UM; Oeseburg, H; Roks, AJ; Simoons, ML; van den Bogaerdt, AJ; Wu, H | 1 |
1 other study(ies) available for bradykinin, des-arg(9)- and Arteriosclerosis, Coronary
Article | Year |
---|---|
Genetic variation and gender determine bradykinin type 1 receptor responses in human tissue: implications for the ACE-inhibitor-induced effects in patients with coronary artery disease.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Chemokine CXCL5; Coronary Artery Disease; Coronary Vessels; Estradiol; Female; Genetic Variation; Genotype; Humans; Inflammation Mediators; Leukocytes, Mononuclear; Male; Middle Aged; Organ Culture Techniques; Polymorphism, Single Nucleotide; Receptor, Bradykinin B1; Sex Characteristics; Sex Factors; Vasodilation; Vasodilator Agents | 2014 |